|
1
|
Gollard R, Jhatakia S, Elliott M and Kosty
M: Large cell/neuroendocrine carcinoma. Lung Cancer. 69:13–18.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun JM, Ahn MJ, Ahn JS, Um SW, Kim H, Kim
HK, Choi YS, Han J, Kim J, Kwon OJ, et al: Chemotherapy for
pulmonary large cell neuroendocrine carcinoma: Similar to that for
small cell lung cancer or non-small cell lung cancer? Lung Cancer.
77:365–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Le Treut J, Sault MC, Lena H, Souquet PJ,
Vergnenegre A, Le Caer H, Berard H, Boffa S, Monnet I, Damotte D
and Chouaid C: Multicentre phase II study of cisplatin-etoposide
chemotherapy for advanced large-cell neuroendocrine lung carcinoma:
The GFPC 0302 study. Ann Oncol. 24:1548–1552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bugiantella W, Cavazzoni E, Graziosi L,
Valiani S, Franceschini MS and Donini A: Small bowel metastasis
from lung cancer: A possible cause of acute abdomen. Case report
and literature review. G Chir. 32:120–122. 2011.PubMed/NCBI
|
|
5
|
Murakawa T, Nakajima J, Fukami T, Tanaka
M, Takeuchi E and Takamoto S: Tonsillar metastasis from large cell
carcinoma of the lung. Jpn J Thorac Cardiovasc Surg. 49:377–380.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nelson BE, Carcangiu ML and Chambers JT:
Intraabdominal hemorrhage with pulmonary large cell carcinoma
metastatic to the ovary. Gynecol Oncol. 47:377–381. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rocconi RP, Leath CA III, Johnson WM III,
Barnes MN III and Conner MG: Primary lung large cell carcinoma
metastatic to the vulva: A case report and review of the
literature. Gynecol Oncol. 94:829–831. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimizu K, Goto T, Maeshima A, Oyamada Y
and Kato R: Prostatic metastasis of pulmonary large cell
neuroendocrine carcinoma. J Cancer. 3:96–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshii T, Muraoka S, Sano N, Furudoi S and
Komori T: Large cell carcinoma of the lung metastatic to the
mandibular gingiva. J Periodontol. 73:571–574. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsimpas A, Post NH, Moshel Y and
Frempong-Boadu AK: Large cell neuroendocrine carcinoma of the lung
metastatic to the cauda equina. Spine J. 10:e1–e5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paydas S, Bicakci K and Yavuz S: Dramatic
response with capecitabine after cranial radiation to the brain
parenchymal and leptomeningeal metastases from lung cancer. Eur J
Intern Med. 20:96–99. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schag CC, Heinrich RL and Ganz PA:
Karnofsky performance status revisited: Reliability, validity, and
guidelines. J Clin Oncol. 2:187–193. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Le Rhun E, Taillibert S and Chamberlain
MC: Carcinomatous meningitis: Leptomeningeal metastases in solid
tumors. Surg Neurol Int. 4:(Suppl 4). S265–S288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Travis WD, Linnoila RI, Tsokos MG,
Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H and
Doppman J: Neuroendocrine tumors of the lung with proposed criteria
for large-cell neuroendocrine carcinoma. An ultrastructural,
immunohistochemical, and flow cytometric study of 35 cases. Am J
Surg Pathol. 15:529–553. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumours. Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamazaki S, Sekine I, Matsuno Y, Takei H,
Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Asamura H, et al:
Clinical responses of large cell neuroendocrine carcinoma of the
lung to cisplatin-based chemotherapy. Lung Cancer. 49:217–223.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niho S, Kenmotsu H, Sekine I, Ishii G,
Ishikawa Y, Noguchi M, Oshita F, Watanabe S, Nakajima R, Tada H and
Nagai K: Combination chemotherapy with irinotecan and cisplatin for
large-cell neuroendocrine carcinoma of the lung: A multicenter
phase II study. J Thorac Oncol. 8:980–984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chamberlain MC, Glantz M, Groves MD and
Wilson WH: Diagnostic tools for neoplastic meningitis: Detecting
disease, identifying patient risk, and determining benefit of
treatment. Semin Oncol. 36:(4 Suppl 2). S35–S45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chamberlain MC, Tsao-Wei D and Groshen S:
Neoplastic meningitis-related encephalopathy: Prognostic
significance. Neurology. 63:2159–2161. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brem SS, Bierman PJ, Black P, Blumenthal
DT, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker
RA, Fine HA, et al: Central nervous system cancers: Clinical
practice guidelines in oncology. J Natl Compr Canc Netw. 3:644–690.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gani C, Müller AC, Eckert F, Schroeder C,
Bender B, Pantazis G, Bamberg M and Berger B: Outcome after whole
brain radiotherapy alone in intracranial leptomeningeal
carcinomatosis from solid tumors. Strahlenther Onkol. 188:148–153.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morris PG, Reiner AS, Szenberg OR, Clarke
JL, Panageas KS, Perez HR, Kris MG, Chan TA, DeAngelis LM and Omuro
AM: Leptomeningeal metastasis from non-small cell lung cancer:
Survival and the impact of whole brain radiotherapy. J Thorac
Oncol. 7:382–385. 2012. View Article : Google Scholar : PubMed/NCBI
|
